U-Blot® Research Grade AmubarvimabCat. No. WA1072Request quote
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade AmubarvimabCat. No. WA1072
U-Blot® Research Grade amtabafusp alfaCat. No. WA1071
U-Blot® Research Grade amrecibartCat. No. WA1070
U-Blot® Research Grade AmostomigCat. No. WA1069
U-Blot® Research Grade AmlitelimabCat. No. WA1068
U-Blot® Research Grade AmlenetugCat. No. WA1067
U-Blot® Research Grade AmivantamabCat. No. WA1066
U-Blot® Research Grade amezosvateinCat. No. WA1065
U-Blot® Research Grade amesotatugCat. No. WA1064
U-Blot® Research Grade amdokitugCat. No. WA1063
U-Blot® Research Grade AmatuximabCat. No. WA1062
U-Blot® Research Grade alveltamigCat. No. WA1061